Silo Pharma (SILO) Competitors $0.63 -0.01 (-1.69%) Closing price 08/29/2025 03:47 PM EasternExtended Trading$0.63 +0.00 (+0.59%) As of 08/29/2025 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SILO vs. EVKG, ONON, LULU, AS, BIRK, GIL, LEVI, KTB, BRP, and ZGNShould you be buying Silo Pharma stock or one of its competitors? The main competitors of Silo Pharma include Ever-Glory International Group (EVKG), ON (ONON), lululemon athletica (LULU), Amer Sports (AS), Birkenstock (BIRK), Gildan Activewear (GIL), Levi Strauss & Co. (LEVI), Kontoor Brands (KTB), The Baldwin Insurance Group (BRP), and Ermenegildo Zegna (ZGN). These companies are all part of the "apparel" industry. Silo Pharma vs. Its Competitors Ever-Glory International Group ON lululemon athletica Amer Sports Birkenstock Gildan Activewear Levi Strauss & Co. Kontoor Brands The Baldwin Insurance Group Ermenegildo Zegna Silo Pharma (NASDAQ:SILO) and Ever-Glory International Group (NASDAQ:EVKG) are both small-cap apparel companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations. Is SILO or EVKG more profitable? Ever-Glory International Group has a net margin of 0.00% compared to Silo Pharma's net margin of -6,798.61%. Ever-Glory International Group's return on equity of 0.00% beat Silo Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Silo Pharma-6,798.61% -94.39% -68.62% Ever-Glory International Group N/A N/A N/A Does the media refer more to SILO or EVKG? In the previous week, Silo Pharma had 1 more articles in the media than Ever-Glory International Group. MarketBeat recorded 1 mentions for Silo Pharma and 0 mentions for Ever-Glory International Group. Silo Pharma's average media sentiment score of 1.87 beat Ever-Glory International Group's score of 0.00 indicating that Silo Pharma is being referred to more favorably in the media. Company Overall Sentiment Silo Pharma Very Positive Ever-Glory International Group Neutral Do institutionals and insiders hold more shares of SILO or EVKG? 5.6% of Silo Pharma shares are owned by institutional investors. 4.4% of Silo Pharma shares are owned by insiders. Comparatively, 35.5% of Ever-Glory International Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has preferable earnings & valuation, SILO or EVKG? Ever-Glory International Group has lower revenue, but higher earnings than Silo Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilo Pharma$72.10K81.92-$4.39M-$1.05-0.60Ever-Glory International GroupN/AN/AN/AN/AN/A Which has more volatility & risk, SILO or EVKG? Silo Pharma has a beta of 0.31, meaning that its share price is 69% less volatile than the S&P 500. Comparatively, Ever-Glory International Group has a beta of 3.97, meaning that its share price is 297% more volatile than the S&P 500. SummaryEver-Glory International Group beats Silo Pharma on 5 of the 9 factors compared between the two stocks. Get Silo Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SILO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SILO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SILO vs. The Competition Export to ExcelMetricSilo PharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.01M$3.06B$5.66B$9.84BDividend YieldN/A2.28%3.93%4.04%P/E Ratio-0.6020.9283.2726.61Price / Sales81.92200.54451.26176.46Price / CashN/A44.0537.7059.65Price / Book1.218.0710.556.59Net Income-$4.39M-$53.98M$3.27B$266.12M7 Day Performance-0.43%-0.88%0.47%0.17%1 Month Performance-9.19%6.20%5.93%3.03%1 Year Performance-46.30%7.13%48.79%19.98% Silo Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SILOSilo Pharma0.207 of 5 stars$0.63-1.7%N/A-47.6%$6.01M$72.10K-0.602EVKGEver-Glory International GroupN/A$0.00flatN/AN/A$10KN/A0.004,300ONONON4.4479 of 5 stars$45.00-0.5%$64.20+42.7%-4.0%$28.47B$2.63B99.993,254Positive NewsLULUlululemon athletica4.6788 of 5 stars$197.66-2.9%$319.98+61.9%-21.9%$24.40B$10.59B13.3939,000Trending NewsAnalyst ForecastASAmer Sports2.8479 of 5 stars$35.75-4.7%$38.74+8.3%+184.0%$20.77B$5.18B96.6313,400Analyst ForecastHigh Trading VolumeBIRKBirkenstock2.6042 of 5 stars$50.16-0.7%$68.58+36.7%+2.5%$9.49B$1.96B27.867,400GILGildan Activewear4.9201 of 5 stars$56.54+0.1%$64.58+14.2%+21.1%$8.43B$3.27B17.9550,000LEVILevi Strauss & Co.3.9586 of 5 stars$20.86-0.9%$23.45+12.5%+17.5%$8.32B$6.36B20.4518,700News CoverageKTBKontoor Brands4.0124 of 5 stars$72.72+1.6%$89.67+23.3%+3.9%$3.98B$2.61B16.2313,200Positive NewsBRPThe Baldwin Insurance GroupN/A$32.69-0.5%N/A-31.9%$3.84B$1.27B-35.539,200ZGNErmenegildo Zegna0.9683 of 5 stars$8.01+0.1%$8.70+8.6%-17.3%$3.26B$2.11B15.127,395Positive NewsUpcoming Earnings Related Companies and Tools Related Companies Ever-Glory International Group Competitors ON Competitors lululemon athletica Competitors Amer Sports Competitors Birkenstock Competitors Gildan Activewear Competitors Levi Strauss & Co. Competitors Kontoor Brands Competitors The Baldwin Insurance Group Competitors Ermenegildo Zegna Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SILO) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silo Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Silo Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
